Novel selective antithrombotic agents may avoid bleeding complications

Victorian researchers are working on a novel class of antithrombotic agent that promises the best of both worlds: by selectively acting on platelets they inhibit thrombosis and yet avoid bleeding complications. Associate Professor Justin Hamilton and colleagues at the Australian Centre for Blood Diseases, Monash University, have developed a series of ‘PI3KC2a inhibitors’ that act ...

Already a member?

Login to keep reading.

© 2021 the limbic